What is High-Sensitivity C-Reactive Protein?
C-reactive protein (CRP) is produced by the liver in response to inflammatory signals , specifically IL-6, a cytokine released by immune cells during infection, tissue damage, or chronic inflammatory states. The high-sensitivity version (hs-CRP) measures very low concentrations of CRP that are not detectable on standard CRP tests, making it the appropriate tool for identifying chronic low-grade inflammation rather than acute infections. It is one of the most widely used inflammatory biomarkers in clinical and research medicine.
hs-CRP is the single most broadly relevant biomarker in peptide research because inflammation is a common denominator across virtually every peptide category. Elevated hs-CRP directly impairs GH secretion and insulin sensitivity , making it relevant before GH secretagogue protocols. High inflammation context justifies anti-inflammatory peptide research (BPC-157, KPV, Thymosin Alpha-1). It is also a primary cardiovascular risk marker , relevant context for GLP-1 agonist research, which has demonstrated hs-CRP reduction in major clinical trials.
What do the numbers mean?
Lab reference ranges vary by laboratory, age, sex, and testing method. Always interpret your results with your healthcare provider , do not self-diagnose based on these ranges.
Why this marker matters before peptide research.
In GH secretagogue research, elevated hs-CRP is associated with blunted GH response , the inflammatory state suppresses pituitary GH pulsatility through multiple mechanisms including elevated somatostatin tone. Addressing underlying inflammation before initiating a GH protocol may improve the magnitude of IGF-1 response and body composition outcomes observed in research. hs-CRP context is therefore relevant not just as a safety check but as a potential explanatory variable when GH protocols underperform expectations.
In recovery and repair peptide research, hs-CRP provides the inflammatory baseline that contextualizes whether compounds like BPC-157 or TB-500 are being studied in a genuinely inflamed environment versus a low-inflammation maintenance context. These are different research scenarios that may produce different observable outcomes. A protocol initiated at hs-CRP of 4.2 mg/L and retested at 1.1 mg/L provides much stronger evidence of anti-inflammatory effect than one initiated at 0.6 mg/L with no meaningful reduction possible.
In metabolic peptide research, baseline hs-CRP establishes cardiovascular risk context and allows researchers to monitor whether GLP-1 agonists are producing the anti-inflammatory effects documented in clinical trials. Semaglutide and Tirzepatide studies have consistently shown meaningful hs-CRP reductions alongside weight loss , understanding whether this effect is occurring in a specific research context requires a pre-protocol baseline.
How to get this test.
Where to order
Standard blood draw at any major lab , LabCorp, Quest Diagnostics, or through your physician. Often included in cardiovascular risk panels. Widely available through direct-to-consumer services without a doctor's order.
How to prepare
Fasting preferred for most consistent results. Critically: do not test during acute illness, recent injury, intense exercise, or high-stress periods , all transiently elevate CRP and will not reflect chronic inflammatory burden. Draw when feeling well and at a normal activity level.
What to ask for
"hs-CRP," "High-Sensitivity CRP," or "High-Sensitivity C-Reactive Protein" , specify the high-sensitivity version. Standard CRP is a different, less sensitive test and is not appropriate for chronic inflammation assessment in research contexts.